Unnamed: 0,title,date,stock,sentiment
849973.0,Monroe Capital Q1 EPS $0.330 Misses $0.350 Estimate,2020-05-08 16:00:00-04:00,MRCC,negative
849974.0,"Oppenheimer Maintains Outperform on Monroe Capital, Lowers Price Target to $10",2020-04-13 09:17:00-04:00,MRCC,negative
849975.0,"B. Riley FBR Maintains Neutral on Monroe Capital, Lowers Price Target to $7",2020-03-24 07:43:00-04:00,MRCC,negative
849976.0,Monroe Capital Q4 EPS $0.37 Beats $0.35 Estimate,2020-03-03 16:02:00-05:00,MRCC,neutral
849977.0,"B. Riley FBR Maintains Neutral on Monroe Capital, Lowers Price Target to $11",2020-01-13 13:19:00-05:00,MRCC,negative
849978.0,"Monroe Capital Q3 EPS $0.35, Inline",2019-11-06 16:11:00-05:00,MRCC,neutral
849979.0,Monroe Capital Q1 Adj. Net Investment Income $0.35,2019-05-07 16:30:00-04:00,MRCC,neutral
849980.0,"Monroe Capital Q4 EPS $0.38 Beats $0.36 Estimate, Sales $14.835M Beat $14.66M Estimate",2019-03-05 16:26:00-05:00,MRCC,neutral
849981.0,"Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018",2018-12-14 11:03:00-05:00,MRCC,negative
849982.0,"Stocks That Will Be Trading Ex Dividend Thurs., Dec. 13, 2018",2018-12-12 11:15:00-05:00,MRCC,neutral
849983.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 7, 2018",2018-11-08 10:52:00-05:00,MRCC,negative
849984.0,JMP Securities Downgrades Monroe Capital to Market Perform,2018-11-07 06:30:00-05:00,MRCC,positive
849985.0,Raymond James Downgrades Monroe Capital to Market Perform,2018-11-07 06:29:00-05:00,MRCC,neutral
849986.0,"Monroe Capital Q3 EPS $0.38 Beats $0.36 Estimate, Sales $13.779M Miss $15.23M Estimate",2018-11-06 17:29:00-05:00,MRCC,negative
849987.0,"Stocks Trading Ex Dividend For Thurs., Sep. 13, 2018",2018-09-14 07:09:00-04:00,MRCC,neutral
849988.0,"Stocks Trading Ex Dividend For Thurs., Sep. 13, 2018",2018-09-13 09:42:00-04:00,MRCC,neutral
849989.0,"Monroe Capital Q2 EPS $0.39 Beats $0.37 Estimate, Total Investment Income $14.82M Down From $14.95M YoY",2018-08-07 16:27:00-04:00,MRCC,neutral
849990.0,"Monroe Capital Q1 Adj. NII/Share $0.42 Beats $0.35 Estimate, Total Investment Income $14.95M Beat $14.61M Estimate",2018-05-08 17:29:00-04:00,MRCC,neutral
849991.0,"B. Riley Initiates Coverage On Monroe Capital with Neutral Rating, Announces $13.50 Price Target",2018-03-28 08:01:00-04:00,MRCC,neutral
849992.0,"Monroe Capital Corporation BDC Reports Q4 Adj. Net Investment Income $0.35 vs $0.35 Est., NAV Of $13.77/Share",2018-03-14 16:03:00-04:00,MRCC,neutral
849993.0,Monroe Capital Reports Q3 Adj. NII/Share $0.35 vs $0.34 Est. NII $6.9M,2017-11-07 16:32:00-05:00,MRCC,neutral
849994.0,Ladenburg Thalmann Upgrades Monroe Capital to Buy,2017-08-10 07:58:00-04:00,MRCC,neutral
849995.0,"Monroe Capital Reports Q2 Adj. Net Investment Income $0.35/Share, Net Asset Value $14.05/Share",2017-08-08 17:36:00-04:00,MRCC,positive
849996.0,Secondary Offering Lockup Expirations Today For Accelerate Diagnostics and Monroe Capital,2017-08-08 08:45:00-04:00,MRCC,neutral
849997.0,"Monroe Capital Announces Offering Common Stock, No Size Disclosed",2017-06-08 16:06:00-04:00,MRCC,negative
849998.0,Monroe Capital Reports Adj. NII/Share $0.35 vs $0.36 Est.,2017-05-09 16:41:00-04:00,MRCC,neutral
849999.0,"Monroe Capital BDC Reports Q4 Adj. Net Investment Income $0.35 vs $0.37 Est., Net Asset Value $14.52/Share",2017-03-07 18:03:00-05:00,MRCC,positive
850000.0,Monroe Capital Corporation Increases Credit Facility From $160M To $200M,2017-02-23 07:38:00-05:00,MRCC,positive
850001.0,Baird Downgrades Monroe Capital to Neutral,2017-01-09 08:03:00-05:00,MRCC,neutral
850002.0,Raymond James Initiates Coverage on Monroe Capital at Outperform,2016-08-16 09:38:00-04:00,MRCC,neutral
850003.0,Ladenburg Thalmann Downgrades Monroe Capital to Neutral,2016-08-10 07:09:00-04:00,MRCC,neutral
850004.0,"Stephens & Co. Initiates Coverage on Monroe Capital at Overweight, Announces $17.00 PT",2015-07-16 08:39:00-04:00,MRCC,negative
850005.0,"Wunderlich Initiates Coverage on Monroe Capital at Buy, Announces $15.50 PT",2015-05-28 06:27:00-04:00,MRCC,neutral
850006.0,"Oppenheimer Initiates Coverage on Monroe Capital at Outperform, Announces $15.00 PT",2015-05-13 08:04:00-04:00,MRCC,neutral
850007.0,"JMP Securities Initiates Coverage on Monroe Capital at Market Perform, Announces $16.00 PT",2015-04-08 06:19:00-04:00,MRCC,positive
850008.0,Monroe Capital Reports Q3 EPS of $0.39 vs $0.36 Est,2014-11-10 07:04:00-05:00,MRCC,neutral
850009.0,Monroe Capital Reports Q2 Net Investment Income of $0.35 vs $0.33 Est,2014-08-11 07:32:00-04:00,MRCC,neutral
850010.0,"Baird Downgrades Monroe Capital to Neutral, Maintains $14.00 PT",2014-06-04 06:17:00-04:00,MRCC,neutral
850011.0,Monroe Capital Reports Q1 EPS of $0.33 vs $0.31 Est,2014-05-12 07:31:00-04:00,MRCC,neutral
850012.0,Monroe Capital Announces Approval for Subsidiary's SBIC License ,2014-03-03 06:09:00-05:00,MRCC,positive
850013.0,National Securities Initiates Coverage on Monroe Capital at Neutral,2014-01-30 09:47:00-05:00,MRCC,positive
850014.0,Monroe Capital Reports Q2 EPS of $0.27 vs $0.32 Est,2013-08-13 08:02:00-04:00,MRCC,neutral
850015.0,Monroe Capital Corporation Closed on Over-Allotment Option by Underwriters Relating to IPO,2012-11-27 06:11:00-05:00,MRCC,neutral
850016.0,"Robert W. Baird Initiated Coverage on Monroe Capital  at Outperform, Announced PT to $16",2012-11-19 09:56:00-05:00,MRCC,neutral
850017.0,Monroe Capital Corporation Closes 5M Share IPO at $15/Share,2012-10-31 06:15:00-04:00,MRCC,positive
